Bacterial infections are illnesses caused by pathogenic bacteria invading tissues or organs. They range from mild localized infections to severe systemic disease and are typically treated with appropriate antibiotics when indicated.
Animal health markets are projected to expand in 2026, led by animal biotechnology at $34.6 billion to $36.19 billion and continued growth in veterinary antibiotics. Demand is being driven by companion animal care, livestock health, biologics R&D, and tighter oversight of antibiotic use.
The World Health Organization published blueprints for urgently needed antibiotics targeting drug-resistant infections, while CARB-X awarded $1.2 million for novel antibiotic research and the FDA issued guidance on antibiotic duration limits in livestock.
Acurx Pharmaceuticals announced a new clinical trial program for ibezapolstat in patients with recurrent C. difficile infection, building on Phase 2 results showing 96% clinical cure rates with no recurrence while sparing the gut microbiome.
Acurx Pharmaceuticals will discuss full year and fourth quarter 2025 financial results on March 13, 2026, and provide updates on ibezapolstat, its lead antibiotic candidate preparing for international Phase 3 trials for C. difficile infection.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07470541 |
Viromes in Infants Presenting With a Septic Syndrome |
NOT_YET_RECRUITING | NA |
| NCT07367295 |
Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial Infections |
NOT_YET_RECRUITING | |
| NCT07207291 |
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers |
RECRUITING | PHASE1 |
| NCT07205575 |
AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness |
COMPLETED | |
| NCT07146217 |
Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection |
NOT_YET_RECRUITING | PHASE2 |
| NCT07113951 |
Diagnostic Application of AI-ROSE in Severe Pneumonia |
ENROLLING_BY_INVITATION | |
| NCT07104162 |
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment |
RECRUITING | PHASE1 |
| NCT07062445 |
Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis |
RECRUITING | |
| NCT07056881 |
Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa |
RECRUITING | |
| NCT07029672 |
The AcCREDiT 2 Study |
NOT_YET_RECRUITING |
